ENTRY       D03978                      Drug
NAME        Eltrombopag olamine (JAN/USAN);
            Promacta (TN)
PRODUCT     PROMACTA (Novartis Pharmaceuticals Corporation)
FORMULA     C25H22N4O4. (C2H7NO)2
EXACT_MASS  564.2696
MOL_WEIGHT  564.6327
REMARK      Therapeutic category: 3999
            ATC code: B02BX05
            Product: D03978<JP/US>
EFFICACY    Antithrombocytopenia, Thrombopoietin receptor agonist
  DISEASE   Chronic immune thrombocytopenia [DS:H01240]
            Aplastic anemia [DS:H01132]
COMMENT     Treatment of chemotherapy-induced thrombocytopenia and treatment of immune thrombocytopenic purpura
TARGET      MPL (TPOR, CD110) [HSA:4352] [KO:K05082]
  PATHWAY   hsa04060(4352)  Cytokine-cytokine receptor interaction
            hsa04630(4352)  JAK-STAT signaling pathway
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             B BLOOD AND BLOOD FORMING ORGANS
              B02 ANTIHEMORRHAGICS
               B02B VITAMIN K AND OTHER HEMOSTATICS
                B02BX Other systemic hemostatics
                 B02BX05 Eltrombopag
                  D03978  Eltrombopag olamine (JAN/USAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Blood Products and Modifiers
              Blood Products and Modifiers, Other
               Blood Products and Modifiers, Micellaneous
                Eltrombopag Olamine
                 D03978  Eltrombopag olamine (JAN/USAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               399  Miscellaneous
                3999  Others
                 D03978  Eltrombopag olamine (JAN/USAN)
            Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               CSF and other factor receptors
                MPL (TPOR, CD110)
                 D03978  Eltrombopag olamine (JAN/USAN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D03978
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D03978
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D03978
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D03978
            Pharmacogenomic biomarkers [br08341.html]
             Polymorphisms and mutations affecting drug response
              D03978
DBLINKS     CAS: 496775-62-3
            PubChem: 47205962
            LigandBox: D03978
ATOM        41
            1   N1a N    35.8702  -19.1003
            2   C1b C    37.0869  -18.3978
            3   C1b C    38.3036  -19.1003
            4   O1a O    39.5203  -18.3978
            5   N2x N    27.1600  -16.3800
            6   C2y C    28.5600  -16.3800
            7   C2y C    28.9926  -15.0485
            8   C5x C    27.8600  -14.2256
            9   N1y N    26.7274  -15.0485
            10  O5x O    27.8600  -12.8100
            11  C8y C    25.5149  -14.3485
            12  C8x C    24.3025  -15.0485
            13  N1b N    31.4175  -15.0485
            14  N2b N    30.2051  -14.3485
            15  C1a C    29.3829  -17.5126
            16  C8x C    25.5149  -12.9485
            17  C8x C    24.3025  -12.2485
            18  C8y C    23.0901  -12.9485
            19  C8y C    23.0901  -14.3485
            20  C8y C    32.6299  -14.3485
            21  C1a C    21.8845  -15.0446
            22  C1a C    21.8857  -12.2532
            23  C8y C    33.8355  -15.0446
            24  C8y C    35.0480  -14.3446
            25  C8x C    35.0480  -12.9446
            26  C8x C    33.8424  -12.2485
            27  C8x C    32.6300  -12.9485
            28  O1a O    33.8356  -16.4498
            29  C8y C    36.2792  -15.0556
            30  C8x C    36.2790  -16.4499
            31  C8x C    37.4913  -17.1501
            32  C8x C    38.7038  -16.4502
            33  C8y C    38.7040  -15.0560
            34  C8x C    37.4917  -14.3558
            35  C6a C    39.9237  -14.3521
            36  O6a O    41.1172  -15.0416
            37  O6a O    39.9240  -12.9502
            38  N1a N    35.8702  -19.1003
            39  C1b C    37.0869  -18.3978
            40  C1b C    38.3036  -19.1003
            41  O1a O    39.5203  -18.3978
BOND        42
            1     5   6 2
            2     6   7 1
            3     7   8 1
            4     8   9 1
            5     5   9 1
            6     8  10 2
            7     9  11 1
            8    11  12 1
            9    13  14 1
            10    7  14 2
            11    6  15 1
            12   11  16 2
            13   16  17 1
            14   17  18 2
            15   18  19 1
            16   12  19 2
            17   13  20 1
            18   19  21 1
            19   18  22 1
            20   20  23 2
            21   23  24 1
            22   24  25 2
            23   25  26 1
            24   26  27 2
            25   20  27 1
            26   23  28 1
            27   24  29 1
            28   29  30 2
            29   30  31 1
            30   31  32 2
            31   32  33 1
            32   33  34 2
            33   29  34 1
            34   33  35 1
            35   35  36 1
            36   35  37 2
            37    1   2 1
            38    2   3 1
            39    3   4 1
            40   38  39 1
            41   39  40 1
            42   40  41 1
BRACKET     1    33.8800  -19.8800   33.8800  -17.6400
            1    40.8100  -17.6400   40.8100  -19.8800
            1  2
  ORIGINAL  1    1   2   3   4
  REPEAT    1   38  39  40  41
///
